GUDIN JEFFREY enters VIRPAX PHARMACEUTICALS, INC. with 2.74M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 2/16/2021ACC: 0001213900-21-009811
DirectorOfficer· Chief Medical Officer
Since Feb 2021
2.74M
Baseline shares
0% direct
7.58K
Direct ownership
1 position
45.51K
Derivative underlying
2 instruments
2
Security positions
2.73M indirect
Non-Derivative Holdings2
Common Stock, $0.00001 par value per share
IndirectShares owned2.73M
Common Stock, $0.00001 par value per share
DirectShares owned7.58K
Total
7.58K direct·2.73M indirect2.74M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.00001 par value per share | 2.73M | Indirect |
| Common Stock, $0.00001 par value per share | 7.58K | Direct |
| Total | 2.74M | 7.58K direct·2.73M indirect |
Derivative Holdings2
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
30.34K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
15.17K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Total
Underlying
45.51K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 30.34K | N/A |
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 15.17K | N/A |
| Total | 45.51K | 0.00 | ||||